Together with the increase in osteoblast number that we observed in vivo, our in vitro data demonstrate that targeted inhibition of IKKβ in osteoblasts enhances their ability to mature even in the presence of breast cancer-derived factors. The gene discussed is IKBKB; the disease is breast carcinoma.